Modeling Huntington's disease with induced pluripotent stem cells
about
sameAs
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future ApplicationsMechanisms and models of endoplasmic reticulum stress in chondrodysplasiaModeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells.Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell DerivationIn Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease.Oligonucleotide-based strategies to combat polyglutamine diseases.Differential nuclear localization of complexes may underlie in vivo intrabody efficacy in Huntington's disease.Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.Direct reprogramming of Huntington's disease patient fibroblasts into neuron-like cells leads to abnormal neurite outgrowth, increased cell death, and aggregate formationiPSC technology--Powerful hand for disease modeling and therapeutic screenLarge-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation.Microarray-Based Comparisons of Ion Channel Expression Patterns: Human Keratinocytes to Reprogrammed hiPSCs to Differentiated Neuronal and Cardiac Progeny.Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.Human-induced pluripotent stem cells: potential for neurodegenerative diseases.Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.Preclinical models: needed in translation? A Pro/Con debate.The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.iPSC-based drug screening for Huntington's disease.Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma.Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.Astrocyte-enriched feeder layers from cryopreserved cells support differentiation of spontaneously active networks of human iPSC-derived neurons.Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.iPS Cells-The Triumphs and Tribulations.
P2860
Q26772309-7BA363DA-CC3F-43D2-B607-9737250F42A0Q26995280-E5757045-401F-4AAD-B09A-6DC296066932Q27687330-BE45CDAD-EBFB-4496-B65B-627051DE6A09Q28066087-F526A2EC-5A0D-4571-8359-37835AAD7696Q33727646-D5DF10FB-9BED-47BE-BCA7-A457D85FE8EFQ33791247-3E34BF01-B1DF-42A2-A8B1-A27ECD51691DQ34313192-8BF0EEF4-6C09-4D21-AE99-FC7142AAB0C2Q35037783-D3FD6B5F-0804-4E80-BC69-9296AA7EF2D5Q35294913-2B67575A-1A1B-481D-BAC0-9299BE28574EQ36082427-C70A4C06-C7C7-4FF7-9BD9-D52D2A0C2CD5Q36125111-44379587-ED95-4EFC-BF4A-17B75276A62BQ36830966-5335314C-DFC3-447C-A1E2-BEF2644860E5Q37652595-AF77A56C-6F65-485D-90F9-E4E0BB295BB1Q37684006-6322EE0A-9F90-4D75-BCD4-D84E31CD8E43Q38123757-F1059264-5928-471C-A886-2A2FC681E3CDQ38211497-6750C374-E790-42D8-B908-961644CF9E51Q38242113-0F6FAA0D-A774-4201-BA4D-3D9377D90DE1Q38248688-9B0C3DC6-D8C4-44B0-9170-E30018807A03Q38349063-E0430758-6BF7-44F8-9E79-E255665F10AAQ38542017-AFF760B4-6134-42ED-A7BC-4D23AE6BA8AAQ38597179-F73266D8-1B30-4893-9D7E-11F2343CD504Q38745828-DFAECE6C-98A8-4569-A34E-17894C787EC8Q38813105-3E8FAA43-39FC-4D3A-B89A-22ECC9BB5B3AQ38884155-7E927909-27ED-4C97-805A-77C1A47A788DQ46724618-BDB08A22-6880-4332-A527-2E7D92741251Q50463961-CE844DE1-599B-4C58-97EF-FCAB250EF7BDQ55398510-C471A5E4-7023-40CC-9CFD-A6B0C514204A
P2860
Modeling Huntington's disease with induced pluripotent stem cells
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Modeling Huntington's disease with induced pluripotent stem cells
@ast
Modeling Huntington's disease with induced pluripotent stem cells
@en
Modeling Huntington's disease with induced pluripotent stem cells
@nl
type
label
Modeling Huntington's disease with induced pluripotent stem cells
@ast
Modeling Huntington's disease with induced pluripotent stem cells
@en
Modeling Huntington's disease with induced pluripotent stem cells
@nl
prefLabel
Modeling Huntington's disease with induced pluripotent stem cells
@ast
Modeling Huntington's disease with induced pluripotent stem cells
@en
Modeling Huntington's disease with induced pluripotent stem cells
@nl
P2860
P3181
P1476
Modeling Huntington's disease with induced pluripotent stem cells
@en
P2093
Julia A. Kaye
Steven Finkbeiner
P2860
P3181
P356
10.1016/J.MCN.2013.02.005
P407
P577
2013-09-01T00:00:00Z